Synthetic virology: engineering viruses for gene delivery

被引:35
|
作者
Guenther, Caitlin M. [1 ]
Kuypers, Brianna E. [2 ]
Lam, Michael T. [1 ]
Robinson, Tawana M. [3 ]
Zhao, Julia [3 ]
Suh, Junghae [1 ,2 ]
机构
[1] Rice Univ, Dept Bioengn, Houston, TX 77005 USA
[2] Rice Univ, Syst Synthet & Phys Biol Program, Houston, TX USA
[3] Rice Univ, Dept Chem, Houston, TX USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
ADENOASSOCIATED VIRAL VECTORS; SITE-SPECIFIC MODIFICATION; IN-VITRO; DIRECTED EVOLUTION; AAV VECTOR; LENTIVIRAL VECTORS; MOLECULAR EVOLUTION; THERAPY VECTOR; CAPSID PROTEIN; ADENOVIRUS;
D O I
10.1002/wnan.1287
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The success of gene therapy relies heavily on the performance of vectors that can effectively deliver transgenes to desired cell populations. As viruses have evolved to deliver genetic material into cells, a prolific area of research has emerged over the last several decades to leverage the innate properties of viruses as well as to engineer new features into them. Specifically, the field of synthetic virology aims to capitalize on knowledge accrued from fundamental virology research in order to design functionally enhanced gene delivery vectors. The enhanced viral vectors, or bionic' viruses, feature engineered components, or parts', that are natural (intrinsic to viruses or from other organisms) and synthetic (such as man-made polymers or inorganic nanoparticles). Various design strategiesrational, combinatorial, and pseudo-rationalhave been pursued to create the hybrid viruses. The gene delivery vectors of the future will likely criss-cross the boundaries between natural and synthetic domains to harness the unique strengths afforded by the various functional parts that can be grafted onto virus capsids. Such research endeavors will further expand and enable enhanced control over the functional capacity of these nanoscale devices for biomedicine. WIREs Nanomed Nanobiotechnol 2014, 6:548-558. doi: 10.1002/wnan.1287 For further resources related to this article, please visit the . Conflict of interest: The authors declare no conflicts of interest.
引用
收藏
页码:548 / 558
页数:11
相关论文
共 50 条
  • [21] VIROLOGY Giant viruses - movers and shakers
    Molloy, Sheilagh
    NATURE REVIEWS MICROBIOLOGY, 2012, 10 (12) : 803 - 803
  • [22] Synthetic virology: the experts speak
    DeFrancesco, Laura
    NATURE BIOTECHNOLOGY, 2021, 39 (10) : 1185 - 1193
  • [23] Artificial viruses: a nanotechnological approach to gene delivery
    Mastrobattista, E
    van der Aa, MAEM
    Hennink, WE
    Crommelin, DJA
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (02) : 115 - 121
  • [24] Artificial viruses: a nanotechnological approach to gene delivery
    Enrico Mastrobattista
    Marieke A. E. M. van der Aa
    Wim E. Hennink
    Daan J. A. Crommelin
    Nature Reviews Drug Discovery, 2006, 5 : 115 - 121
  • [25] Nonviral gene delivery: Towards artificial viruses
    Belguise-Valladier, P
    Behr, JP
    CYTOTECHNOLOGY, 2001, 35 (03) : 197 - 201
  • [26] Nonviral gene delivery: Towards artificial viruses
    Pascale Belguise-Valladier
    Jean-Paul Behr
    Cytotechnology, 2001, 35 : 197 - 201
  • [27] THE USE OF SYNTHETIC OLIGOPEPTIDES IN VIROLOGY
    TRUYEN, U
    KAADEN, OR
    DEUTSCHE TIERARZTLICHE WOCHENSCHRIFT, 1989, 96 (02): : 69 - 72
  • [28] Synthetic virology: the experts speak
    Laura DeFrancesco
    Nature Biotechnology, 2021, 39 : 1185 - 1193
  • [29] Gene delivery the key to gene therapy: the case for foamy viruses
    Erlwein, Otto
    McClure, Myra
    THERAPEUTIC DELIVERY, 2011, 2 (06) : 681 - 684
  • [30] Synthetic materials at the forefront of gene delivery
    Irene Lostalé-Seijo
    Javier Montenegro
    Nature Reviews Chemistry, 2018, 2 : 258 - 277